Home Lilly And ImaginAb Announce Preclinical Immuno-Oncology Collaboration
 

Keywords :   


Lilly And ImaginAb Announce Preclinical Immuno-Oncology Collaboration

2015-10-14 06:26:33| drugdiscoveryonline News Articles

Eli Lilly and Company (NYSE: LLY) and ImaginAb Inc. are pleased to announce a preclinical research collaboration to study potential novel T-cell-based immuno-oncology therapies.

Tags: collaboration announce lilly preclinical

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11
23.11 NEXT
23.11
23.11(Rawlings)
23.11 DVD2
23.11
23.11 US Orig LP The Soul Searchers Salt Of ~
23.11Switch SR SL LED 2
More »